tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Ownership - Who Owns Crispr Therapeutics AG?

7,548 Followers

Crispr Therapeutics AG (CRSP) Ownership Overview

23.58%16.98%28.65%30.79%
23.58% Insiders
28.65% Other Institutional Investors
30.79% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 45.63% of the company’s stock is owned by Institutional Investors, 23.58% is owned by Insiders and 30.79% is owned by Public Companies and Individual Investors.
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 45.63% of the company’s stock is owned by Institutional Investors, 23.58% is owned by Insiders and 30.79% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 21, 2024
James R. Kasinger
Gc & Secretary
Sold$152409

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$208270
Dec 31, 2023Bought$327147
Dec 31, 2023Sold$3132065
Dec 31, 2023Bought$534360110

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,157,028Institution9.61%460,137,949
7,336,761Institution8.64%413,866,688
3,550,544Institution4.18%200,286,187
1,462,065Institution1.72%82,475,087
1,191,100Institution1.40%67,189,951
1,180,449Institution1.39%66,589,128
1,150,219Institution1.36%64,883,854
1,052,256Institution1.24%59,357,761
974,053Institution1.15%54,946,330
902,543Institution1.06%50,912,451

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,550,544Institution4.18%200,286,187
1,191,100Institution1.40%67,189,951
1,180,449Institution1.39%66,589,128
1,052,256Institution1.24%59,357,761
902,543Institution1.06%50,912,451
798,425Institution0.94%45,039,154
798,191Institution0.94%45,025,954
528,990Institution0.62%29,840,326
455,000Institution0.54%25,666,550
402,458Institution0.47%22,702,656

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,602,394Institution6.60%316,031,046
1,734,367Institution2.04%97,835,642
1,189,400Institution1.40%81,069,504
951,350Institution1.12%53,665,654
597,902Institution0.70%33,727,652
376,135Institution0.44%21,217,775
256,856Institution0.30%17,507,305
226,351Institution0.27%12,598,697
217,195Institution0.26%12,251,970
85,891Institution0.10%4,845,111

FAQ

Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 28.65% of the company's stock is held by institutional investors, 23.58% is held by insiders, and 30.79% is held by retail investors.
    What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 28.65% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
      What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.79% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
        Who owns the most shares of Crispr Therapeutics AG (CRSP)?
        Cathie Wood owns the most shares of Crispr Therapeutics AG (CRSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis